DMG — Dr Miele Cosmed SA Income Statement
0.000.00%
Last trade - 00:00
- PLN432.33m
- PLN484.50m
- PLN444.48m
- 93
- 45
- 67
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 310 | 365 | 352 | 397 | 444 |
Cost of Revenue | |||||
Gross Profit | 125 | 160 | 133 | 125 | 172 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 301 | 333 | 337 | 395 | 411 |
Operating Profit | 8.6 | 31.9 | 15.1 | 1.31 | 33 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.93 | 31.3 | 13.3 | -2.1 | 27.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.35 | 28.6 | 11.6 | -2.27 | 22.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.35 | 28.6 | 11.6 | -2.27 | 22.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.35 | 28.6 | 11.6 | -2.27 | 22.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.031 | 0.306 | 0.135 | -0.018 | 0.253 |
Dividends per Share |